Nyelia Williams
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
20
Citations
79
Est. group size
~34
Recurring co-author estimate
Active years
6
Publishing since 2021
Nyelia Williams studies how the microbiome (the bacteria, fungi, and other microorganisms living in and on the body) affects cancer treatment outcomes, particularly responses to immunotherapy and radiotherapy. This work spans preclinical mouse models and clinical studies, looking at gut, vaginal, and tumor-associated microbes in cancers such as melanoma, lung, and cervical cancer, including how age and dietary interventions like berry supplements might modify these effects.
Publication output has grown substantially over the past decade, rising from no recorded output before 2021 to a peak of 7 publications in 2024, with continued activity in 2025 and 2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Abstract 6529: Vaginal microbiome dynamics and clinical outcomes in cervical cancer patients undergoing radiotherapy
Cancer Research · 2026
- Abstract 2861: Comparative genomics of gut commensal <i>Lachnospiraceae</i> and their associations with cancer treatment response with immune checkpoint inhibitors
Cancer Research · 2026
- Berry Supplement-Modified Human Microbiome Improves Immunotherapy Response in Mouse Models
medRxiv · 2025
- Abstract 4693: Impact of pelvic radiation on vaginal microbiome and pelvic health: Findings from the GEORGIA Trial (NCT04713618)
Cancer Research · 2025
- The Association of the Microbiome with Melanoma Tumor Response to Immune Checkpoint Inhibitor Treatment and Immune-Related Adverse Events (NCT05102773)
medRxiv · 2025
- Abstract 2377: Gut microbiome modulation by a black raspberry nectar for improving anti-PD1 therapy effectiveness in pre-clinical cancer models
Cancer Research · 2025
- Obesity-associated microbiomes instigate visceral adipose tissue inflammation by recruitment of distinct neutrophils
Nature Communications · 2024
- Abstract 1282: Gavage with <i>Candida albicans</i> leads to fungal colonization of colorectal tumors and decreased response to radiotherapy
Cancer Research · 2024
- Abstract 6842: The effect of intra-tumoral <i>Candida albicans</i> on host gene expression
Cancer Research · 2024
- Mouse RNASeq data for "An explainable graph neural framework to identify cancer-associated intratumoral microbial communities"
Zenodo (CERN European Organization for Nuclear Research) · 2024
- Mouse RNASeq data for "An explainable graph neural framework to identify cancer-associated intratumoral microbial communities"
Zenodo (CERN European Organization for Nuclear Research) · 2024
- The FITNESS study: longitudinal geriatric assessment, treatment toxicity, and biospecimen collection to assess functional disability among older adults with lung cancer
Frontiers in Aging · 2024
- Abstract 4435: A causal modeling platform for testing lifestyle interventions on the microbiome and response to immunotherapy
Cancer Research · 2023
- De-correlating immune checkpoint inhibitor toxicity and response in melanoma via the microbiome.
Journal of Clinical Oncology · 2023
- Abstract PR004: Older adult-specific microbes correlate with treatment response and markers of T-cell senescence in NSCLC
Cancer Research · 2023
- Cancer Research×10
- Journal of Geriatric Oncology×2
- Journal of Clinical Oncology×2
- medRxiv×2
- Zenodo (CERN European Organization for Nuclear Research)×2
- Amna Bibi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Shankar Suman
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Shiva Jahanbakhshi
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- YunZhou Liu
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Andrea R. Merchak
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile